Performance characteristics of the UniCel DxI 800 Immunoassay for the maternal serum quadruple test, including median values for each week of gestation, in Korean women

Korean Journal of Laboratory Medicine

Volumn 30, Issue 2, 2010, Pages 126-132

  Lee, Jeong Hoon ^a   Park, Yongjung ^a   Suh, Borum ^a   Song, Seon Mi ^b   Kwon, Oh Hun ^a   Kim, Jeong Ho ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Seoul Medical Science Institute   (South Korea)

Author keywords

Down syndrome; Immunoassay; Prenatal screening; Quadruple test

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN;

ARTICLE; BLOOD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; INSTRUMENTATION; METHODOLOGY; PREGNANCY; PRENATAL DIAGNOSIS; REFERENCE VALUE; SECOND TRIMESTER PREGNANCY; SOUTH KOREA;

ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRIOL; FEMALE; GESTATIONAL AGE; HUMANS; IMMUNOASSAY; INHIBINS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; REFERENCE VALUES; REPUBLIC OF KOREA;

EID: 77954840888     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2010.30.2.126     Document Type: Article

References (21)

1. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988;297:883-7.
2. Egan JF, Kaminsky LM, DeRoche ME, Barsoom MJ, Borgida AF, Benn PA. Antenatal Down syndrome screening in the United States in 2001: a survey of maternal-fetal medicine specialists. Am J Obstet Gynecol 2002;187:1230-4.
3. Kim JM, Sim AS, Lee EH. Amniotic chromosomal analysis in pregnant women identified by triple-marker testing as screen positive. Korean J Lab Med 2006;26:123-30.
4. Kim SK, Bai SW, Chung JE, Jung YN, Park KH, Cho DJ, et al. Triple marker screening for fetal chromosomal abnormalities in Korean women of advanced maternal age. Yonsei Med J 2001;42:199-203.
5. Han SH, An JW, Jeong GY, Yoon HR, Lee A, Yang YH, et al. Clinical and cytogenetic findings on 31,615 mid-trimester amniocenteses. Korean J Lab Med 2008;28:378-85.
6. Benn PA, Kaminsky LM, Ying J, Borgida AF, Egan JF. Combined second-trimester biochemical and ultrasound screening for Down syndrome. Obstet Gynecol 2002;100:1168-76.
7. Benn PA, Fang M, Egan JF, Horne D, Collins R. Incorporation of inhibin-A in second-trimester screening for Down syndrome. Obstet Gynecol 2003;101:451-4.
8. Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. SURUSS in perspective. Semin Perinatol 2005;29:225-35.
9. Lambert-Messerlian GM, Palomaki GE, Canick JA. Inhibin A measurement using an automated assay platform. Prenat Diagn 2008; 28:399-403.
10. National Committee for Clinical Laboratory Standards. Evaluation of precision performance of quantitative measurement methods: approved guideline. NCCLS document EP5-A2. 2nd ed. Wayne, PA: NCCLS, 2004.
11. Rawlins ML, La'ulu SL, Erickson JA, Roberts WL. Performance characteristics of the Access Inhibin A assay. Clin Chim Acta 2008;397: 32-5.
12. Erickson JA, Ashwood ER, Gin CA. Evaluation of a dimeric inhibin-A assay for assessing fetal Down syndrome: establishment, comparison, and monitoring of median concentrations for normal pregnancies. Arch Pathol Lab Med 2004;128:415-20.
13. Vranken G, Reynolds T, Van Nueten J. Medians for second-trimester maternal serum markers: geographical differences and variation caused by median multiples-of-median equations. J Clin Pathol 2006; 59:639-44.
14. Crandall BF, Lebherz TB, Schroth PC, Matsumoto M. Alpha-fetoprotein concentrations in maternal serum: relation to race and body weight. Clin Chem 1983;29:531-3.
15. Bogart MH, Jones OW, Felder RA, Best RG, Bradley L, Butts W, et al. Prospective evaluation of maternal serum human chorionic gonadotropin levels in 3428 pregnancies. Am J Obstet Gynecol 1991;165: 663-7.
16. Simpson JL, Elias S, Morgan CD, Shulman L, Umstot E, Andersen RN. Second trimester maternal serum human chorionic gonadotropin and unconjugated oestriol levels in blacks and whites. Lancet 1990;335:1459-60.
17. Benn PA, Clive JM, Collins R. Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups. Clin Chem 1997;43:333-7.
18. Benn PA and Collins R. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome. Ann Clin Biochem 2001;38:28-36.
19. Serdar MA, Tutuncu L, Olgun A, Hasimi A, Ozgurtas T, Erbil MK. The effects of analytical factors on second trimester risk estimations. Int J Gynaecol Obstet 2006;93:28-32.
20. Wald NJ, Bestwick JP, Huttly WJ, Morris JK, George LM. Validation plots in antenatal screening for Down's syndrome. J Med Screen 2006;13:166-71.
21. Kim S, Kim YH, Min WK. Prenatal serum marker screening in Korea: survey results. Korean J Lab Med 2007;27:28-33.